Latest News

The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 16th...

Key Insights The considerable ownership by public companies in Topicus.com indicates that they collectively have a...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Investors may wish to note that the First Senior VP & Director of Mortgage Lending of Unity Bancorp, Inc. , Vincent...

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...

While CSW Industrials, Inc. ( NYSE:CSW ) might not have the largest market cap around , it saw a significant share...

Siebert Financial Corp. ( NASDAQ:SIEB ) shareholders won't be pleased to see that the share price has had a very rough...

GreenFirst Forest Products Inc. ( TSE:GFP ) shareholders would be excited to see that the share price has had a great...

CarMax, Inc. ( NYSE:KMX ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...

Key Insights Significantly high institutional ownership implies Aldeyra Therapeutics' stock price is sensitive to their...

Strong U.S. growth projections and record highs in the Russell 2000 have pulled Texas Roadhouse (TXRH) into focus as investors reassess earnings potential across small and mid cap restaurant names. See our latest analysis for Texas Roadhouse. The recent move in Texas Roadhouse ties into a broader shift toward small and mid caps, with a 10.65% 1 month share price return and a 165.75% 5 year total shareholder return pointing to firm, longer running momentum supported by improving growth...

Last week, White Gold Corp. ( CVE:WGO ) insiders, who had purchased shares in the previous 12 months were rewarded...

Recent commentary on Mueller Industries highlights the company’s strong balance sheet, debt-free position, and resilient performance across plumbing, HVAC, and infrastructure-related markets, reinforcing its status as a Growth at a Reasonable Price industrial name. An interesting angle is management’s ongoing emphasis on high returns on invested capital and disciplined capital allocation, which reinforces investor confidence in the company’s steady, real-economy demand profile. We’ll now...

Some THOR Industries, Inc. ( NYSE:THO ) shareholders may be a little concerned to see that the Senior VP & COO, W...

In the past week, IDACORP’s board declared a quarterly common dividend of US$0.88 per share, payable on March 2, 2026 to shareholders of record as of February 5, 2026, while its Idaho Power subsidiary secured regulatory approval for a US$110 million rate increase effective January 2026. Together with supportive analyst coverage, this combination of dividend income and approved rate relief highlights the importance of regulation and capital returns in IDACORP’s investment case. Building on...

Viatris recently appointed Lara Ramsburg as Chief People and Corporate Affairs Officer, combining global HR, talent, and corporate affairs responsibilities to support its ongoing transformation and strengthen internal and external stakeholder communications. This expanded role places culture, employee experience, and reputation management under a single leader, reinforcing Viatris’ effort to align its workforce with its more focused portfolio and corporate priorities. We’ll now examine how...

Ventas stock reaction and key metrics Ventas (VTR) has been drawing fresh attention after recent share price moves, with the stock closing at US$78.45 and showing mixed returns over the past week, month and past 3 months. For context, the real estate investment trust reports annual revenue of US$5.54b and net income of US$238.01m, with recent annual revenue and net income growth figures of 13.07% and 24.79% respectively. See our latest analysis for Ventas. Recent trading reflects a pick up in...

In the days leading up to its January 22, 2026 earnings release, Columbia Banking System drew attention as analysts projected year-over-year earnings and revenue increases while trimming consensus EPS estimates. The combination of expectations for improved quarterly performance and a negative Earnings ESP with a Zacks Rank of #4 highlighted a cautious tone around the likelihood of another earnings beat. With mixed analyst sentiment and downward EPS revisions in focus, we’ll now examine how...

Independent Bank Corporation recently declared a quarterly cash dividend of US$0.28 per share, payable on February 13, 2026, to shareholders of record on February 3, 2026, marking the thirteenth consecutive annual increase and highlighting its focus on ongoing cash returns to investors. This thirteenth straight annual dividend raise underscores the bank’s emphasis on capital strength and consistent shareholder payouts as a core part of its business profile. We’ll now examine how this latest...

Shelf registration puts potential capital raise in focus Titan Mining (TSX:TI) has filed a $150 million omnibus shelf registration covering common shares, debt securities, warrants, and units. This filing gives the company flexibility to issue securities over time if market conditions and project needs align. See our latest analysis for Titan Mining. The shelf filing comes as Titan Mining’s share price has moved sharply, with a 4.09% 1 day and 64.71% 30 day share price return, while the 1...

Administradora de Fondos de Pensiones Cuprum S.A.'s ( SNSE:CUPRUM ) price-to-earnings (or "P/E") ratio of 20.9x might...

If you are wondering whether Revolution Medicines at around US$120 per share reflects its real worth, you are not alone. This article is designed to help you frame that question clearly. The stock closed at US$120.28 recently, with returns of 1.4% over 7 days, 52.7% over 30 days, 52.2% year to date, 198.5% over 1 year and 337.1% over 3 years, which naturally raises questions about how expectations and risk are being priced in. Recent news flow around Revolution Medicines has focused on its...

Earlier this month, ORIC Pharmaceuticals presented its oncology pipeline at the 44th Annual J.P. Morgan Healthcare Conference, highlighting progress on ORIC-944 in metastatic castration-resistant prostate cancer and enozertinib for EGFR exon 20 insertion-positive non-small cell lung cancer. Investor interest has been reinforced by encouraging clinical data, provisional Phase 2 dosing decisions, and a collaboration with Johnson & Johnson to test enozertinib with amivantamab in first-line lung...

Cboe Global Markets (CBOE) has been in focus after reporting quarterly results that showed higher revenue and profit than a year earlier, which has increased analyst attention. The company also decided to close its Cboe Europe Derivatives exchange. See our latest analysis for Cboe Global Markets. At a share price of $273.55, Cboe Global Markets has seen firm momentum build recently, with a 10.63% 1 month share price return and a 15.38% 3 month share price return, while the 1 year total...